I'm window shopping for shares again, and there are plenty of goodies for sale. Should I pop Petrofac� (LSE: PFC ) into my basket?
Just the 'facs
These are tough times for oil stocks, with Brent crude falling below $100 a barrel on fears of a China and U.S. slowdown and weak demand from Europe. Oil services company Petrofac looked cheap last month, when you could buy it for around 拢15. Today, you would pay just 拢13.40. Is this a great time to buy?
Petrofac's share price is now down a meaty 20% over the last three months, despite signing a couple of lucrative contracts in April. Last week, it announced it had won the lion's share of a $3.7 billion deal to develop oil fields for the Abu Dhabi National Oil Company. That followed a $500 million contract from the Abu Dhabi Marine Operating Company. My suspicions that Petrofac is being unfairly punished by a wider market sell-off were confirmed by its recent full-year results, which revealed a 17% rise in profits, neatly matched with a 17% dividend hike.
Best Integrated Utility Companies To Watch For 2015: Takeda Pharmaceutical Co Ltd (TKPHF.PK)
Takeda Pharmaceutical Company Limited is a Japan-based company engaged in the pharmaceutical business. The Company operates in three business segments. The Ethical Pharmaceutical segment is engaged in the manufacture and sale of pharmaceutical products, such as therapeutic substances for diabetes, circulatory drugs, anticancer drugs, drugs for central neurological diseases, digestive system drugs, hormonal agents, osteoporosis drugs, antibiotic agents, allergy medications, vitamin drops and vaccines, among others. The Healthcare segment manufactures and sells general drugs and medicines, as well as quasi drugs. The Others segment is involved in the manufacture and sale of reagents, clinical diagnostics and chemical products. Advisors' Opinion:- [By Alpha Exposure]
The most recent Affymax article states that Takeda withdrew from consideration for European approval "because they were doing the "root cause analysis" they would not be able to complete the investigation because it was still in process and "ongoing" despite the fact that severe reactions were not present at the time of the clinical trials." However, there is no evidence to support this conclusion. The truth is that we showed you an excerpt directly from the Committee for Medicinal Products for Human Use that stated the CHMP "was of the provisional opinion that Omontys could not have been approved" due to "study results indicating that Omontys may increase the risk of death or heart and circulatory problems." It is clear that the EU application was withdrawn because Takeda (TKPHF.PK) could not get Omontys approved due to its safety profile.
- [By Markus Aarnio]
Companies working on chemically synthesized siRNAs include Merck (MRK), through its subsidiary Sirna Therapeutics, Inc., Novartis (NVS), Takeda (TKPHF.PK), Kyowa Hakko Kirin, Marina Biotech, Inc., Arrowhead and its subsidiary, Calando, Quark, Silence Therapeutics plc, Tekmira (TKMR), Sylentis and Dicerna Pharmaceuticals, Inc.
Top 5 Oil Service Companies For 2014: Gafisa SA (GFA)
Gafisa S.A. (Gafisa), incorporated on November 12, 1996, is a diversified national homebuilder serving all demographic segments of the Brazilian market. The Company�� brands include Tenda, which serves the affordable entry-level housing segments, Gafisa, which offers a variety of residential options to the mid to higher income segments and Alphaville, which focuses on the identification, development and sale of residential communities. In addition, it provides construction services to third parties. Gafisa�� core business is the development of residential units in attractive locations. During the year ended December 31, 2009, approximately 55% of the value of its launches was derived from high and mid high-level residential developments under the Gafisa brand. It is also engaged in the development of land subdivisions, also known as residential communities, representing approximately 18% of the value of its launches under the Alphaville brand, and affordable entry-level housing, which represents approximately 27% of the value of its launches under the Tenda brand. In addition, it provides construction services to third parties. Gafisa operates in more than 120 cities, including Sao Paulo, Rio de Janeiro, Salvador, Fortaleza, Natal, Curitiba, Belo Horizonte, Manaus, Porto Alegre and Belem, across 21 states and the Federal District.
Real Estate Activities
The Company�� real estate business includes developments for sale of residential units; land subdivisions (also known as residential communities); commercial buildings; construction services to third parties, and sale of units through its brokerage subsidiaries, Gafisa Vendas and Gafisa Vendas Rio, jointly referred to as Gafisa Vendas. In the residential buildings product category, Gafisa develops three main types of products: luxury buildings targeted at upper-income customers, buildings targeted at middle-income customers; and affordable entry-level housing targeted at lower-income customers. Quality residential buildi! ngs for middle- and upper-income customers are its core products. Luxury buildings units usually have over 180 square meters of private area, at least four bedrooms and three parking spaces. The development includes swimming pools, gyms, visitor parking, and other amenities.
Buildings targeted at middle-income customers have accounted for the majority of its sales. Units usually have between 90 and 180 square meters of private area, three or four bedrooms and two to three underground parking spaces. Buildings are usually developed in large tracts of land as part of multi-building developments and, to a lesser extent, in smaller lots in attractive neighborhoods. Affordable entry-level housing consists of building and house units. Units usually have between 42 to 60 square meters of indoor private area and two to three bedrooms.
Commercial Buildings
During 2009, the Company launched four commercial buildings. These buildings include Centro Empresarial Madureira, Paulista Corporate, Reserva Eco Office Life and Global Offices.
Construction Service
Gafisa provide construction services to third parties, building residential and commercial projects for developers in Brazil. The Company�� principal construction services clients are large companies, many of them developers that do not build their own projects. As of December 31, 2009, its principal construction services clients were Fibra Empreendimentos Imobiliarios S.A., Sisan-Grupo Silvio Santos, Camargo Correa Desenvolvimento Imobiliario S.A., Helbor Empreendimentos Imobiliarios Ltda., InCons S.A., SDI Desenvolvimento Imobiliario Ltda. and Abyara. It also provides construction services on certain developments where it retains an equity interest.
Advisors' Opinion:- [By Eric Volkman]
Brazilian construction firm Gafisa (NYSE: GFA ) is not only selling houses these days. The company has signed an agreement to sell a 70% stake in residential community developer Alphaville Urbanismo to funds managed by Blackstone (NYSE: BX ) and the American company's Brazilian partner firm Patria Investimentos.
- [By Jon C. Ogg]
Gafisa S.A. (NYSE: GFA) is a homebuilder in Brazil, supposedly with more than $1 billion in projects for 2014 alone. This ADR trades at $3.05 against a 52-week range of $2.22 to $5.24, and this is down only about 2% so far in 2014.
Top 5 Oil Service Companies For 2014: Cytokinetics Incorporated(CYTK)
Cytokinetics, Incorporated, a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions. It primarily offers omecamtiv mecarbil, a cardiac muscle myosin activator, which is in Phase I/IIa clinical trials for the treatment of heart failure; CK-2017357, which is a Phase IIa clinical trials for the treatment of amyotrophic lateral sclerosis; and CK-2066260, a fast skeletal muscle sarcomere activator for the treatment of diseases and conditions associated with muscle weakness or wasting. The company?s cancer treatment products under development stage comprise ispinesib, SB-743921, and GSK-923295. It has a strategic alliance with Amgen Inc. to discover, develop, and commercialize novel small molecule therapeutics that activate cardiac muscle contractility for applications in the treatment of heart failure. The company was founded in 1997 and is headquartered in South San Francisco, California.
Advisors' Opinion:- [By John Udovich]
Small cap ALS and stem cell stock�Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI) surged 22.68%�ahead if its Monday ice bucket challenge when they will release the final results from�a phase 2a clinical trial���meaning its worth taking a closer look at the stock along with the performance of stem cell stocks or ALS stocks like Cytokinetics, Inc (NASDAQ: CYTK), Neuralstem, Inc (NYSEMKT: CUR) and NeoStem Inc (NASDAQ: NBS). However, Brainstorm Cell Therapeutics does have a history of being the subject of paid promotions and/or investor relations activities when it was trading on the OTC.
Top 5 Oil Service Companies For 2014: ITC Holdings Corp. (ITC)
ITC Holdings Corp., through its subsidiaries, engages in the transmission of electricity in the United States. The company operates as conduits, allowing for power from generators to be transmitted to local distribution systems either entirely through its own systems or in conjunction with neighboring transmission systems. Its operations include asset planning; engineering, design, and construction; maintenance; and real time operations. ITC Holdings serves investor-owned utilities, municipalities, cooperatives, power marketers, and alternative energy suppliers. The company was founded in 2001 and is based in Novi, Michigan.
Advisors' Opinion:- [By Rich Duprey]
Electricity transmission company�ITC Holdings (NYSE: ITC ) announced today its third-quarter dividend of $0.425 per share, a 13% increase in the payout made to investors last quarter of $0.3775�per share.
- [By Brian Pacampara]
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, electricity transmission specialist ITC Holdings (NYSE: ITC ) has earned a coveted five-star ranking.
- [By Rajhkumar K Shaaw]
India�� S&P BSE Sensex ended three weeks of gains as Bharat Heavy Electricals Ltd., the largest maker of power equipment, slumped to a one-month low. ITC Ltd. (ITC), India�� biggest tobacco company, slid after its sales trailed estimates.
No comments:
Post a Comment